Clinical Trial Update: A Dye for the Detection of Cancer of the Tongue and Mouth [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating a fluorescent dye for detecting cancers of the tongue and mouth in oral squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Dye for Detection of Oral Cancer (investigational) (Unspecified fluorescent dye)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Oral Squamous Cell Carcinoma (OSCC) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING